EX-FILING FEES 4 tm244881d2_ex-filingfees.htm EX-FILING FEES

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-1
(Form Type)

 

Seelos Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

  Security
Type		 Security
Class Title		 Fee
Calculation
or Carry
Forward
Rule		 Amount
Registered
(1)		 Proposed
Maximum
Offering
Price per
Unit		 Maximum
Aggregate
Offering
Price		 Fee Rate Amount
of
Registration
Fee		 Carry
Forward
Form Type		 Carry
Forward
File
Number		 Carry
Forward
Initial
Effective
Date		 Filing Fee
Previously
Paid in
Connection
with Unsold
Securities
to be
Carried
Forward
Newly Registered Securities
Fees to Be Paid Equity Common Stock, par value $0.001 per share, underlying warrants Rule 457(c) 3,404,256 $1.02(2) $3,472,341.12 0.0001476 $512.52 ___ ___ ___ ___
  Total Offering Amounts   $3,472,341.12   $512.52        
  Total Fees Previously Paid       ___        
  Total Fee Offsets       ___        
  Net Fee Due       $512.52        

 

(1)        Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional securities that may be offered, issued or become issuable in connection with any stock split, stock dividend or similar transaction or pursuant to anti-dilution provisions of any of the securities.

 

(2)        Estimated solely for the purpose of calculation of the registration fee pursuant to Rule 457(c) under the Securities Act based on a per share price of $1.02, the average of the high and low reported sales prices of the registrant’s common stock on the Nasdaq Capital Market on January 26, 2024, a date within five business days prior to the filing of this registration statement.